MESA LABORATORIES INC /CO/ (MLAB) research

MESA LABORATORIES INC /CO/
ShareXLinkedInReddit
Sector
Life Sciences Tools & Services
Last price
$133.01
As of

MESA LABORATORIES INC /CO/ (MLAB): 5 institutional managers tracked by Kresmion reported non-option positions in their 2026Q2 Form 13F filings, and the most recent SEC filing on record for the company is a Form 8-K filed 2026-09-08.

As of . Source: SEC EDGAR filings for MLAB. Method and limitations.

SHARE THIS CARD

Share the MLAB intelligence card

A branded snapshot of MLAB: the smart money composite, cross family confluence, and the top current signal, with a link back to this page. Post it, download it, or embed it anywhere.

Kresmion MLAB intelligence card preview
Post to X
LIVE TERMINAL

See MLAB live in the terminal

Track MLAB's insider trades, 13F flows, options positioning, and cross asset confluence as they update, on one live board. Free account.

Open the live MLAB terminal, free

Active signals for MLAB

FREE, NO ACCOUNT

Every signal on MLAB, as it fires

You are seeing 5 of 11 signals recorded on MLAB since 2026-05-26.

The five above landed across 3 days. The other 6 were recorded on 3 other days.

Get it by email

No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.

Join on Telegram
Join on Telegram

One tap. Live alerts, no email needed.

Largest reported share positions in MLAB (2026Q2)

Manager / securityMarket value% portfolioQoQ
D. E. Shaw & Co., Inc.CUSIP 59064R109 · 2026Q2$8.1M0.00%,
CITADEL ADVISORS LLCCUSIP 59064R109 · 2026Q2$3.6M0.00%,
TWO SIGMA INVESTMENTS, LPCUSIP 59064R109 · 2026Q2$2.9M0.00%,
RENAISSANCE TECHNOLOGIES LLCCUSIP 59064R109 · 2026Q2$2.9M0.00%,
Point72 Asset Management, L.P.CUSIP 59064R109 · 2026Q2$2.2M0.00%,

Quarterly SEC Form 13F disclosures from the managers Kresmion tracks, not a complete ownership ranking. Non-option holdings only; reported put and call positions are excluded. Different securities are labeled by CUSIP. Values are reporting-period snapshots, not current position values. Filings can arrive up to 45 days after quarter-end.

Recent SEC filings, MLAB

MLAB against its peers

MLAB's operating margin of 7.4% ranks in the 69th percentile of 23 Life Sciences Tools & Services sub-industry peers, fiscal periods ending between 2025-10-31 and 2026-06-30.

MetricMLABPeer medianPercentilen
Revenue FY249M USD1.2B USD3725
Gross margin63.5%53.7%6512
Operating margin7.4%-19.9%6923
Net margin2.7%-8.1%6325
Return on equity3.6%-12.3%7024
P / E109.9x40.4x859

Peers (25): CTKB, OABI, DNA, MRVI, PACB, FTRE, CDXS, MXCT, ABCL, ADPT, SEER, SHC, BRKR, RGEN, TXG, AVTR, TEM, TECH, CRL, MEDP, MTD, ILMN, WAT, A, IQV. Fiscal periods ending between 2025-10-31 and 2026-06-30. Every figure is one full fiscal year read from one annual filing (MLAB: 10-K), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.

Related tickers

See more MLAB signals as they fire

Kresmion publishes filings, 13F flows, on-chain whale activity, and cross-asset signals in real time. Open a live board scoped to MLABand get the insider, 13F, options, and confluence read in one view.

Open the live MLAB terminal, free